Physician profile
Molly K Easter
NPI 1225224728
$1,106.23
in general payments reported to CMS, 2019-2025
16 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $224 · 2023: $382 · 2024: $205 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.36 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $223.56 | 2023-2025 | Veozah |
| Abbvie INC. | $150.60 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $103.75 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $99.91 | 2021-2023 | |
| Organon LLC | $75.93 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $65.68 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $64.32 | 2022-2024 | |
| Exact Sciences Corporation | $61.01 | 2023-2025 | Cologuard Collection Kit |
| Biogen, INC. | $45.95 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $45.95 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $44.82 | 2022 | |
| Novo Nordisk INC | $43.98 | 2024 | Wegovy |
| Sanofi Pasteur INC. | $23.61 | 2024 | |
| Avion Pharmaceuticals | $21.63 | 2021 | |
| Exeltis, USA INC. | $20.72 | 2023 | Slynd |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $14.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Easter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.